As the Australian Government approaches negotiations with Medicines Australia and the Generic and Biosimilar Medicines Association for new agreements, the organisation says it is not acceptable to exclude patients, as it has in the past.
Patients move to reclaim access agenda ahead of sector negotiations
July 15, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Noxopharm moves lupus skin therapy toward next human trial
September 14, 2026 - - Australian Biotech -
Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends
September 14, 2026 - - Latest News -
Diabetes and cancer blood tests reach WA and NT patients under new Healius deal
September 14, 2026 - - Australian Biotech -
FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug
September 14, 2026 - - Australian Biotech -
Canberra details tax changes with limited concessions for some innovators
September 14, 2026 - - Latest News -
Scandal-hit KPMG still holds $37 million in health department work
September 14, 2026 - - Latest News -
Todd Stephenson confirmed on ACT list for New Zealand election
September 14, 2026 - - Latest News
